Information for "Phase Only two study associated with afatinib amid patients together with repeated andor metastatic esophageal squamous cell carcinoma"
From EECH Central
Basic information
Display title | Phase Only two study associated with afatinib amid patients together with repeated andor metastatic esophageal squamous cell carcinoma |
Default sort key | Phase Only two study associated with afatinib amid patients together with repeated andor metastatic esophageal squamous cell carcinoma |
Page length (in bytes) | 3,531 |
Page ID | 1312315 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Elbowwound75 (Talk | contribs) |
Date of page creation | 10:29, 28 March 2024 |
Latest editor | Elbowwound75 (Talk | contribs) |
Date of latest edit | 10:29, 28 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |